KalVista Pharmaceuticals, Inc. Liquidation Value
KALV
Other
Cash & Equivalents
$243.50M
As of 2025-09-30
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $243.50M
Total Obligations: -$55.63M
$187.87M
Per share: $3.72
Period: 2025-09-30
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $243.50M
AR: $5.78M
Total Obligations: -$55.63M
$193.65M
Per share: $3.83
Period: 2025-09-30
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $243.50M
AR: $5.78M
Inventory: $458,000
Total Obligations: -$55.63M
$194.11M
Per share: $3.84
Period: 2025-09-30
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $187.87M | $3.72 |
| Liquid Liquidation Value | $193.65M | $3.83 |
| Operating Liquidation Value | $194.11M | $3.84 |
Key Components (as of 2025-09-30)
| Cash & Equivalents | $243.50M |
| Accounts Receivable | $5.78M |
| Inventory | $458,000 |
| Current Liabilities | $45.07M |
| Long-term Debt | N/A |
| Op. Lease Liability | $10.56M |
| Finance Lease | N/A |
| Shares Outstanding | 50.5M |
Explore all 193 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | $243.50M | $5.78M | $458,000 | $8.07M | $45.07M | N/A | $10.56M | N/A |
| 2025-07-31 | $124.30M | $1.93M | N/A | $5.87M | $38.38M | N/A | $6.14M | N/A |
| 2025-04-30 | $131.62M | N/A | N/A | $4.88M | $45.17M | N/A | $6.31M | N/A |
| 2025-01-31 | $167.29M | N/A | N/A | $5.86M | $25.61M | N/A | $5.78M | N/A |
| 2024-12-31 | $182.33M | N/A | N/A | $5.73M | $26.11M | N/A | $5.89M | N/A |
| 2024-10-31 | $41.58M | N/A | N/A | $5.20M | $22.16M | N/A | $5.78M | N/A |
| 2024-09-30 | $40.60M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-07-31 | $31.85M | N/A | N/A | $10.79M | $22.41M | N/A | $6.25M | N/A |
▼ Community Notes